Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Novartis' kidney tumor treatment Votubia gains EU OK
The European Commission approved Novartis' Votubia, or everolimus, to treat noncancerous kidney tumors in patients with tuberous sclerosis complex.
Reuters (11/5)
Or we can send an email on your behalf